CA2491451A1 - Novel pharmaceutical compositions comprising novel anticholinergic agents and nk1-receptor antagonists - Google Patents

Novel pharmaceutical compositions comprising novel anticholinergic agents and nk1-receptor antagonists Download PDF

Info

Publication number
CA2491451A1
CA2491451A1 CA002491451A CA2491451A CA2491451A1 CA 2491451 A1 CA2491451 A1 CA 2491451A1 CA 002491451 A CA002491451 A CA 002491451A CA 2491451 A CA2491451 A CA 2491451A CA 2491451 A1 CA2491451 A1 CA 2491451A1
Authority
CA
Canada
Prior art keywords
phenyl
acid
alkyl
inhalable
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002491451A
Other languages
English (en)
French (fr)
Inventor
Michel Pairet
Christopher John Montague Meade
Michael P. Pieper
Birgit Jung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2491451A1 publication Critical patent/CA2491451A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002491451A 2002-07-09 2003-06-25 Novel pharmaceutical compositions comprising novel anticholinergic agents and nk1-receptor antagonists Abandoned CA2491451A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10230750.4 2002-07-09
DE10230750A DE10230750A1 (de) 2002-07-09 2002-07-09 Neue Arzneimittelkompositionen auf der Basis neuer Anticholonergika und NK1-Rezeptor-Antagonisten
PCT/EP2003/006667 WO2004004724A1 (de) 2002-07-09 2003-06-25 Neue arzneimittelkompositionen auf der basis neuer anticholinergika und nk1-rezeptor-antagonisten

Publications (1)

Publication Number Publication Date
CA2491451A1 true CA2491451A1 (en) 2004-01-15

Family

ID=29761745

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002491451A Abandoned CA2491451A1 (en) 2002-07-09 2003-06-25 Novel pharmaceutical compositions comprising novel anticholinergic agents and nk1-receptor antagonists

Country Status (6)

Country Link
EP (1) EP1521580A1 (de)
JP (1) JP2005532378A (de)
AU (1) AU2003242754A1 (de)
CA (1) CA2491451A1 (de)
DE (1) DE10230750A1 (de)
WO (1) WO2004004724A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1740553A1 (de) * 2004-04-14 2007-01-10 AstraZeneca AB Arylglycinamidderivate und deren verwendung als nk1-antagonisten und serotoninwiederaufnahmehemmer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW449590B (en) * 1995-04-14 2001-08-11 Boehringer Ingelheim Kg New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds
DE19608665A1 (de) * 1996-03-06 1997-09-11 Boehringer Ingelheim Kg Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10051320A1 (de) * 2000-10-17 2002-04-25 Boehringer Ingelheim Pharma Neue Neurokininantagonisten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE10111058A1 (de) * 2001-03-08 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten
WO2002051440A1 (fr) * 2000-12-22 2002-07-04 Takeda Chemical Industries, Ltd. Medicaments de combinaison

Also Published As

Publication number Publication date
JP2005532378A (ja) 2005-10-27
DE10230750A1 (de) 2004-01-22
AU2003242754A1 (en) 2004-01-23
WO2004004724A1 (de) 2004-01-15
EP1521580A1 (de) 2005-04-13

Similar Documents

Publication Publication Date Title
CA2431565C (en) Pharmaceutical compositions based on anticholinergics and ciclesonide
CA2455167C (en) New pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
CA2481468C (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
US20040058950A1 (en) Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
US20030212075A1 (en) Pharmaceutical compositions based on anticholinergics and nk1-receptor antagonists
US6608054B2 (en) Pharmaceutical compositions based on anticholinergics and endothelin antagonists
US20020193392A1 (en) Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
CA2429012A1 (en) New pharmaceutical compositions based on tiotropium salts and salts of salmeterol
CA2434872A1 (en) Medicament compositions with negligible side-effects containing betamimetics
US20040048886A1 (en) Pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists
NZ538834A (en) Pharmaceutical compositions for inhalation containing a new anticholinergic in conjunction with corticosteroids and betamimetics
US20040002502A1 (en) Medicament combinations comprising heterocyclic compounds and a novel anticholinergic
EP1651224B1 (de) Medikamente für inhalationen enthaltend ein anticholinergikum und ein betamimetikum
CA2582207A1 (en) Inhalation medicament containing an anticholinesterase drug, salmeterol and a steroid selected from the ciclesonide or mometasone furoate group
NZ545442A (en) Medicaments for inhalation comprising betamimetics and an aclidinium salt known as 3-(2-hydroxy-2,2-dithiophen-2-yl-acetoxy)-1-(3-phenoxypropyl)-l-azoniabicyclo[2.2.2]octane
AU2003216921B2 (en) Medicaments containing steroids and a novel anticholinesterase drug
CA2492026A1 (en) New pharmaceutical compositions based on new anticholinergics and pde-iv inhibitors
CA2436510A1 (en) Pharmaceutical compositions with few side effects
CA2441964C (en) New pharmaceutical compositions based on anticholinergics and endothelin antagonists
CA2436537C (en) Pharmaceutical compositions comprising tiotropium salts and antihistamines
EP1732590A2 (de) Neue pharmazeutische zusammensetzung auf basis von fluorencarbonsäureestern und lösliche tnf-rezeptor-fusionsproteinen
CA2527178A1 (en) New long-acting drug combinations for the treatment of respiratory complaints
EP1651221A1 (de) Medikamente zur inhalation mit betamimetika und einem anticholinergikum
CA2491451A1 (en) Novel pharmaceutical compositions comprising novel anticholinergic agents and nk1-receptor antagonists
CA2507656C (en) Tiotropium-containing medicament combinations used for inhaling

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead